Analysts think RCEL stock price could increase by 36%
Dec 27, 2024, 12:26 PM
-29.23%
What does RCEL do
AVITA Medical, headquartered in Valencia, California, specializes in point-of-care autologous skin restoration using its RECELL platform for treating burn injuries and skin defects. The company went public on March 18, 2012, and employs 207 people.
6 analysts think RCEL stock price will increase by 35.54%. The current median analyst target is $17.85 compared to a current stock price of $13.17. The lowest analysts target is $12.12 and the highest analyst target is $22.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.